Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced HCC Previously Treated With Sorafenib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial
JAMA Oncol 2020 Oct 01;[EPub Ahead of Print], T Yau, YK Kang, TY Kim, AB El-Khoueiry, A Santoro, B Sangro, I Melero, M Kudo, MM Hou, A Matilla, F Tovoli, JJ Knox, A Ruth He, BF El-Rayes, M Acosta-Rivera, HY Lim, J Neely, Y Shen, T Wisniewski, J Anderson, C HsuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.